| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.79B | 11.95B | 12.99B | 14.28B | 13.40B | 10.42B |
| Gross Profit | 1.55B | 1.70B | 2.06B | 2.54B | 2.94B | 1.33B |
| EBITDA | 1.33B | 1.55B | 3.33B | 2.35B | 2.76B | 1.32B |
| Net Income | 1.03B | 1.07B | 2.38B | 1.64B | 1.50B | 745.49M |
Balance Sheet | ||||||
| Total Assets | 24.57B | 24.08B | 24.32B | 23.50B | 21.43B | 20.75B |
| Cash, Cash Equivalents and Short-Term Investments | 13.69B | 13.51B | 13.74B | 12.55B | 11.23B | 10.17B |
| Total Debt | 2.34B | 2.12B | 2.02B | 2.08B | 1.05B | 1.98B |
| Total Liabilities | 5.00B | 4.57B | 4.91B | 5.72B | 4.52B | 5.12B |
| Stockholders Equity | 18.49B | 18.41B | 18.30B | 16.75B | 15.83B | 14.70B |
Cash Flow | ||||||
| Free Cash Flow | 238.05M | 918.02M | 800.48M | 806.70M | 1.88B | 890.36M |
| Operating Cash Flow | 638.95M | 1.52B | 1.54B | 2.14B | 2.94B | 1.26B |
| Investing Cash Flow | -505.34M | -379.00M | -691.13M | -2.35B | -3.66B | 1.11B |
| Financing Cash Flow | -172.77M | -1.06B | -784.06M | 56.35M | -1.37B | -415.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$12.90B | 8.25 | 15.41% | 3.23% | 0.82% | 2.99% | |
71 Outperform | HK$10.68B | 8.91 | 10.34% | 3.66% | -0.34% | 64.10% | |
69 Neutral | HK$11.89B | 10.76 | 5.60% | 5.44% | -8.24% | -24.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
49 Neutral | HK$1.79B | -48.68 | -1.08% | ― | -23.46% | -126.64% | |
47 Neutral | HK$13.94B | -4.64 | -12.42% | ― | -14.20% | 8.19% | |
37 Underperform | HK$672.18M | -18.53 | -44.61% | ― | -5.79% | -129.73% |